Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

It sounds like alchemy: doctors treating rheumatoid arthritis with the beloved base metal gold. Popularized in the 1920s by ...

Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes ...

Medically reviewed by David Ozeri, MD Psoriatic arthritis and rheumatoid arthritis (RA) are both forms of inflammatory arthritis. They each cause chronic swelling, stiffness, and pain in your joints.

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Guselkumab, whether administered every 4 or 8 weeks, demonstrates “significant inhibition” of structural damage in patients ...

Medically reviewed by Stella Bard, MD It's possible to develop psoriatic arthritis (PsA) without psoriasis, a related chronic (long-lasting) skin condition that usually develops first. How Common Is ...

Modifiable lifestyle factors significantly affect the incidence of psoriatic disease, cardiometabolic comorbidities, and all-cause mortality.

J&J files Tremfya in psoriatic arthritis, its second indication, setting up what could be a brutal battle for market share . Skip to main content Thursday 26 June 2025 . BlueSky linkedin youtube ...

Patients with JIA who received tofacitinib vs placebo achieved higher rates of clinically inactive disease and remission.

There’s a stronger relationship between psoriasis and psoriatic arthritis. It’s estimated that between 20 and 30 percent of people with psoriasis also have psoriatic arthritis. [ 5 ] ...